2070-43-1Relevant articles and documents
1,3-Benzoxazole-4-carbonitrile as a novel antifungal scaffold of β-1,6-glucan synthesis inhibitors
Kuroyanagi, Jun-Ichi,Kanai, Kazuo,Sugimoto, Yuuichi,Horiuchi, Takao,Achiwa, Issei,Takeshita, Hiroshi,Kawakami, Katsuhiro
experimental part, p. 7593 - 7606 (2011/01/04)
Synthesis and in vitro antifungal evaluations of 1,3-benzoxazole-7- carbonitrile 3, 1,3-benzoxazole-4-carbonitrile 4, benzofuran 5, benzoxazine 7, and benzimidazole 8 were reported. Among them, 1,3-benzoxazole-4-carbonitrile was found to be a superior sca
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 55-56, (2009/04/25)
Compounds of formula (I) and salts thereof are provided: formula (I) wherein R4, R5, R6, Q, A, and Y are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treatin
BICYCLO HETEROCYCLIC COMPOUND HAVING ANTIFUNGAL ACTION
-
Page/Page column 58, (2008/06/13)
It is intended to provide a 1,6-β-glucan synthase inhibitor which strongly inhibits proliferation and has a high safety. It is intended to provide a compound which can specifically or selectively expressing an antifungal action on a broad spectrum based on the action mechanism of inhibiting the synthesis of 1,6-β-glucan. Further, it is intended to provide a drug, in particular, an antifungal agent containing the above compound, its salt or a hydrate thereof. More specifically speaking, a compound represented by the following general formula (I), its salt or a hydrate thereof; and a drug or an antifungal agent containing the above compound, its salt or a hydrate thereof.
